Your browser doesn't support javascript.
loading
Grip strength values and cut-off points based on over 200,000 adults of the German National Cohort - a comparison to the EWGSOP2 cut-off points.
Huemer, Marie-Theres; Kluttig, Alexander; Fischer, Beate; Ahrens, Wolfgang; Castell, Stefanie; Ebert, Nina; Gastell, Sylvia; Jöckel, Karl-Heinz; Kaaks, Rudolf; Karch, André; Keil, Thomas; Kemmling, Yvonne; Krist, Lilian; Leitzmann, Michael; Lieb, Wolfgang; Meinke-Franze, Claudia; Michels, Karin B; Mikolajczyk, Rafael; Moreno Velásquez, Ilais; Pischon, Tobias; Schipf, Sabine; Schmidt, Börge; Schöttker, Ben; Schulze, Matthias B; Stocker, Hannah; Teismann, Henning; Wirkner, Kerstin; Drey, Michael; Peters, Annette; Thorand, Barbara.
Afiliação
  • Huemer MT; Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Neuherberg, Germany.
  • Kluttig A; Institute of Medical Epidemiology, Biometrics and Informatics, Interdisciplinary Center for Health Sciences, Medical Faculty of the Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.
  • Fischer B; Department of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany.
  • Ahrens W; Leibniz Institute for Prevention Research and Epidemiology - BIPS, Bremen, Germany.
  • Castell S; Department for Epidemiology, Helmholtz Centre for Infection Research, Braunschweig, Germany.
  • Ebert N; Institute for Biometrics and Epidemiology, German Diabetes Center, Leibniz Institute for Diabetes Research at Heinrich Heine University, Dusseldorf, Germany.
  • Gastell S; NAKO Study Center South Berlin/Brandenburg, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
  • Jöckel KH; Institut für Medizinische Informatik, Biometrie und Epidemiologie, Universitätsklinikum Essen, Essen, Germany.
  • Kaaks R; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Karch A; Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany.
  • Keil T; Institute of Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Kemmling Y; Institute of Clinical Epidemiology and Biometry, University of Würzburg, Würzburg, Germany.
  • Krist L; State Institute of Health, Bavarian Health and Food Safety Authority, Erlangen, Germany.
  • Leitzmann M; Department for Epidemiology, Helmholtz Centre for Infection Research, Braunschweig, Germany.
  • Lieb W; Institute of Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Meinke-Franze C; Department of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany.
  • Michels KB; Institute of Epidemiology, Kiel University, Kiel, Germany.
  • Mikolajczyk R; Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany.
  • Moreno Velásquez I; Institute for Prevention and Cancer Epidemiology, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany.
  • Pischon T; Institute of Medical Epidemiology, Biometrics and Informatics, Interdisciplinary Center for Health Sciences, Medical Faculty of the Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.
  • Schipf S; Max-Delbrueck-Center for Molecular Medicine in the Helmholtz Association (MDC), Molecular Epidemiology Research Group, Berlin, Germany.
  • Schmidt B; Max-Delbrueck-Center for Molecular Medicine in the Helmholtz Association (MDC), Molecular Epidemiology Research Group, Berlin, Germany.
  • Schöttker B; Max-Delbrueck-Center for Molecular Medicine in the Helmholtz Association (MDC), Biobank Technology Platform, Berlin, Germany.
  • Schulze MB; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Core Facility Biobank, Berlin, Germany.
  • Stocker H; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Teismann H; Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany.
  • Wirkner K; Institut für Medizinische Informatik, Biometrie und Epidemiologie, Universitätsklinikum Essen, Essen, Germany.
  • Drey M; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Peters A; Network Aging Research, Heidelberg University, Heidelberg, Germany.
  • Thorand B; Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
Age Ageing ; 52(1)2023 01 08.
Article em En | MEDLINE | ID: mdl-36702514
ABSTRACT

BACKGROUND:

The European Working Group on Sarcopenia in Older People (EWGSOP) updated in 2018 the cut-off points for low grip strength to assess sarcopenia based on pooled data from 12 British studies.

OBJECTIVE:

Comparison of the EWGSOP2 cut-off points for low grip strength to those derived from a large German sample.

METHODS:

We assessed the grip strength distribution across age and derived low grip strength cut-off points for men and women (peak mean -2.5 × SD) based on 200,389 German National Cohort (NAKO) participants aged 19-75 years. In 1,012 Cooperative Health Research in the Region of Augsburg (KORA)-Age participants aged 65-93 years, we calculated the age-standardised prevalence of low grip strength and time-dependent sensitivity and specificity for all-cause mortality.

RESULTS:

Grip strength increased in the third and fourth decade of life and declined afterwards. Calculated cut-off points for low grip strength were 29 kg for men and 18 kg for women. In KORA-Age, the age-standardised prevalence of low grip strength was 1.5× higher for NAKO-derived (17.7%) compared to EWGSOP2 (11.7%) cut-off points. NAKO-derived cut-off points yielded a higher sensitivity and lower specificity for all-cause mortality.

CONCLUSIONS:

Cut-off points for low grip strength from German population-based data were 2 kg higher than the EWGSOP2 cut-off points. Higher cut-off points increase the sensitivity, thereby suggesting an intervention for more patients at risk, while other individuals might receive additional diagnostics/treatment without the urgent need. Research on the effectiveness of intervention in patients with low grip strength defined by different cut-off points is needed.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sarcopenia Tipo de estudo: Diagnostic_studies / Prevalence_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sarcopenia Tipo de estudo: Diagnostic_studies / Prevalence_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article